Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China By Investing.com

Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten

SOUTH SAN FRANCISCO, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) — Cytokinetics (NASDAQ:), Incorporated…

www.investing.com

More posts

Ofra Strauss: New factory in north is our response

January 22, 2025
People with high intellectual potential often have these four habits without knowing they reflect their intelligence

January 22, 2025
No one cares if you roll in on time anymore, but here are the behaviors co-workers do mind

January 22, 2025
Google unveils classroom and accessibility ChromeOS features, including rolling out a tool to let users control a device with their head and facial expressions (Antonio G. Di Benedetto/The Verge)

January 22, 2025